Evidence map›Paper›PMID 41892436›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Characterization of an

Qingyuan Zhang, Xiaohong Xie, Lixin Tao, Jian Wang, Yuan Shi, Huangfei Sheng, Chuanlong Liu, Hongwei Zhao, Meihua Liu, Jun Feng

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qingyuan ZhangShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.ORCID 0000-0002-4611-2468
Xiaohong XieShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Lixin TaoShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Jian WangShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Yuan ShiShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Huangfei ShengShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Chuanlong LiuShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Hongwei ZhaoShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Meihua LiuShanghai Fengxian Center for Disease Control and Prevention, Shanghai Fengxian Health Supervision Institute, Shanghai 201499, China.
Jun FengShanghai Municipal Center for Disease Control and Prevention, Shanghai 201107, China.ORCID 0000-0002-5798-0797

Funding

The Science And Technology Development Fund (Social Sector) Of Fengxian, Shanghai No. 20250806
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blaNDM-5Escherichia coliIncHI2mcr-1.1urban WWTPs

Identifiers

PMID41892436
PMCPMC13024088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.